Study on the Correlation Between Fat Soluble Vitamins and Non-alcoholic Fatty Liver Disease
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Zhong Liu, MD
- Phone Number: +86 13957104885
- Email: liuzhongzheyi@zju.edu.cn
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310003
- Recruiting
- First affiliated Hospital of Zhejiang University
-
Contact:
- Zhong Liu, MD
- Phone Number: +86 13957104885
- Email: liuzhongzheyi@zju.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≥ 18 years old, both male and female;
- Voluntarily participate in this study and sign an informed consent form;
- Diagnosed NAFLD through abdominal ultrasound;
Exclusion Criteria:
- Acute and chronic infections, severe cardiovascular and cerebrovascular diseases, respiratory system diseases, urinary system diseases, rheumatic diseases, tumors, and pituitary dysfunction; Or have hepatitis B, hepatitis C virus, or acquired immunodeficiency syndrome;
- Surgery was performed within 6 months, and blood donation, transfusion, or significant blood loss occurred within 4 months;
- Have taken vitamin supplements within 2 weeks;
- Women are in pregnancy, lactation, or within one year after childbirth;
- Alcohol abuse (alcohol intake ≥ 140 g/week for males and ≥ 70 g/week for females)
- The serum creatinine (SCr) exceeds twice the following abnormal values, with the standard of abnormal values being: male (20-59 years old)>97 μ mol/L, male (60-79 years old)>111 μ mol/L; Female (20-59 years old)>73 μ mol/L, female (60-79 years old)>81 μ mol/L.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
non-alcoholic fatty liver disease prevanlence
Time Frame: Day 1
|
Day 1
|
|
serum vitamin A
Time Frame: Day 1
|
Day 1
|
|
serum vitamin D
Time Frame: Day 1
|
Day 1
|
|
serum vitamin E
Time Frame: Day 1
|
Day 1
|
|
serum vitamin k
Time Frame: Day 1
|
Day 1
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Zhong Liu, MD, First affiliated Hospital of Zhejiang University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 20240727
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.